Herbal medicines for menopausal symptoms

Drug and Therapeutics Bulletin

Volumn 47, Issue 1, 2009, Pages 2-6

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANGELICA SINENSIS EXTRACT; ANTICOAGULANT AGENT; CHAMOMILE; CIMICIFUGA RACEMOSA EXTRACT; CONJUGATED ESTROGEN; DIOSCOREA VILLOSA EXTRACT; ESTRADIOL; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HUMULUS LUPULUS EXTRACT; HYPERICUM PERFORATUM EXTRACT; KAVA EXTRACT; LETROZOLE; MEDICAGO SATIVA EXTRACT; MENOHERB; PHENOTHIAZINE; PHYTOESTROGEN; PLANT EXTRACT; PRIMROSE OIL; RED CLOVER EXTRACT; SALVIA OFFICINALIS EXTRACT; TAMOXIFEN; TIBOLONE; UNCLASSIFIED DRUG; VITEX AGNUS CASTUS EXTRACT; WARFARIN; PLANT MEDICINAL PRODUCT;

ALFALFA; ANGELICA SINENSIS; ANXIETY DISORDER; BREAST CANCER; CIMICIFUGA RACEMOSA; CLINICAL TRIAL; DIZZINESS; ENDOMETRIUM HYPERPLASIA; EVENING PRIMROSE; FEMALE; GASTROINTESTINAL SYMPTOM; GINSENG; HEADACHE; HEART INFARCTION; HERBAL MEDICINE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; LIVER INJURY; LIVER TOXICITY; MENOPAUSE; MENOPAUSE SYMPTOM; NIGHT SWEAT; OVARY CANCER; PHOTOSENSITIVITY; RED CLOVER; RESTLESSNESS; REVIEW; SEIZURE; SLEEP DISORDER; STROKE; THROMBOEMBOLISM; UNITED KINGDOM; YAM; DRUG EFFECT; PHYTOTHERAPY; RANDOMIZED CONTROLLED TRIAL;

FEMALE; HUMANS; MENOPAUSE; PHYTOTHERAPY; PLANT PREPARATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 67650093770     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2008.12.0031     Document Type: Review

References (61)

1. Medicines and Healthcare products Regulatory Agency. Hormone-replacement therapy: updated advice. Drug Safety Update 2007; 1: 2-4.
2. Million Women Study Collaborators. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet 2003; 362: 419-27.
3. Million Women Study Collaborators. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 2007; 369 : 1-8.
4. Canonico M et al. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ 2008; 336: 1227-31.
5. Rossouw JE et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007; 297: 1465-77.
6. Hendrix SL et al. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 2006; 113: 2425-34.
7. Cumming GP et al. Women's attitudes to hormone replacement therapy, alternative therapy and sexual health: a web-based survey. Menopause Int 2007; 13: 79-83.
8. Hardy R, Kuh D. Social and environmental conditions across the life course and age at menopause in a British birth cohort study. BJOG 2005; 112: 346-54.
9. Freeman EW, Sherif K. Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric 2007; 10: 197-214.
10. Melby MK et al. Culture and symptom reporting at menopause. Hum Reprod Update 2005; 11: 495-512.
11. Politi MC et al. Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. J Gen Intern Med 2008; 23: 1507-13.
12. Rees M, Hope S 2008. Alternative and Complementary Therapies [online]. Available: http://www.thebms.org.uk/php?id=3 [Accessed 22 December 2008].
13. Royal College of Obstetricians and Gynaecologists, 2006. Alternatives to HRT for management of symptoms of the menopause. Scientific Advisory Committee Opinion Paper 6 [online]. Available: http://www.rcog.org.uk/ resources/Public/pdf/alternatives-to-hrt-sac-paper6.pdf [Accessed 22 December 2008].
14. Medicines Control Agency, 2002. Safety of herbal medicinal products [online]. Available: http://www.mhra.gov.uk/home/groups/es-herbal/ documents/websiteresources/con009293.pdf [Accessed 22 December 2008].
15. Huntley A. Drug-herb interactions with herbal medicines for menopause. J Br Menopause Soc 2004; December: 162-5.
16. Hu Z et al. Herb-drug interactions: a literature review. Drugs 2005; 65: 1239-82.
17. Medicines and Healthcare products Regulatory Agency, 2008. Public health risk with herbal medicines: an overview [online]. Available: http://www.mhra.gov.uk/home/idcplg?IdcService=GET-FILE&dDocName= CON023163&RevisionSelecti onMethod=Latest [Accessed 22 December 2008].
18. European Commission, 2004. Directive 2004/24/EC of the European Parliament and of the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union 2004; 136: 85-90. [online]. Available: http://www.mhra.gov.uk/home/ groups/esherbal/documents/websiteresources/con009359.pdf [Accessed 22 December 2008].
19. Medicines and Healthcare products Regulatory Agency, 2007. Traditional Herbal Medicines Registration Scheme. Guidance for retailers, wholesalers, importers and manufacturers on the requirements of the THMRS [online]. Available: http://www.mhra.gov.uk/home/idcplg?IdcService=6FT-FILE&dDocName= CON2030651&RevisionSelectionMethod=Latest [Accessed 22 December 2008].
20. Nedrow A et al. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med 2006; 166: 1453-65.
21. Reed SD et al. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Menopause 2008; 15: 51-8.
22. Bai W et al. Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone. Maturitas 2007; 58: 31-41.
23. Newton KM et al. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006; 145: 869-79.
24. 1. J Clin Oncol 2006; 24: 2836-41.
25. Frei-Kleiner S et al. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Maturitas 2005; 51: 397-404.
26. Nappi RE et al. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol 2005; 20: 30-5.
27. Osmers R et al. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Obstet Gynecol 2005; 105: 1074-83.
28. Wuttke W et al. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003; 44 (suppl 1): S67-77.
29. Barnes J et al. Herbal Medicines. Third edition. London: Pharmaceutical Press, 2007.
30. Medicines and Healthcare products Regulatory Agency 2007. Menoherb Filmcoated Tablets. THR 23056/0003. UKPAR [online]. Available: http://www.mhra.gov.uk/home/groups/l-unit1/documents/websiteresources/ con2032094.pdf [Accessed 22 December 2008].
31. Chung DJ et al. Black cohosh and St. John's wort (GYNO-Plus) for climacteric symptoms. Yonsei Med J 2007; 48: 289-94.
32. Uebelhack R et al. Black cohosh and St. John's wort for climacteric complaints: a randomized trial. Obstet Gynecol 2006; 107: 247-55.
33. Chitturi S, Farrell GC. Hepatotoxic slimming aids and other herbal hepatotoxins. J Gastroenterol Hepatol 2008; 23: 366-73.
34. Mahady GB et al. United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 2008; 15: 628-38.
35. Medicines and Healthcare products Regulatory Agency. Black Cohosh UK Public Assessment Report [online]. Available: http://www.mhra.gov.uk/home/ groups/es-herbal/documents/websiteresources/con2024279.pdf [Accessed 22 December 2008].
36. Bolle P et al. Estrogen-like effect of a Cimicifuga racemosa extract sub-fraction as assessed by in vivo, ex vivo and in vitro assays. J Steroid Biochem Mol Biol 2007; 107: 262-9.
37. Rice S et al. Ethanolic extracts of black cohosh (Actaea racemosa) inhibit growth and oestradiol synthesis from oestrone sulphate in breast cancer cells. Maturitas 2007; 56: 359-67.
38. Dugoua JJ et al. Safety and efficacy of black cohosh (Cimicifuga racemosa) during pregnancy and lactation. Can J Clin Pharmacol 2006;13: e257-61.
39. Cassidy A et al. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women. Am J Clin Nutr 1994; 60: 333-40.
40. Lethaby AE et al. Phytoestrogens for vasomotor menopausal symptoms. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD001395. DOI: 10.1002/14651858.CD001395.pub3 [Date of most recent substantive amendment 27 July 2007].
41. Thompson Coon JT et al. Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta-analysis. Phytomedicine 2007; 14: 153-9.
42. Nelson HD et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA 2006; 295: 2057-71.
43. Krebs EE et al. Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstet Gynecol 2004; 104: 824-36.
44. Howes LG et al. Isoflavone therapy for menopausal flushes: a systematic review and meta-analysis. Maturitas 2006; 55: 203-11.
45. Powles TJ et al. Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer. Menopause Int 2008; 14: 6-12.
46. Unfer V et al. Endometrial effects of long-term treatment with phytoestrogens: a randomized, double-blind, placebo-controlled study. Fertil Steril 2004; 82: 145-8.
47. Palacios S et al. Endometrial safety assessment of a specific and standardized soy extract according to international guidelines. Menopause 2007; 14: 1006-11.
48. Ju YH et al. Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice. Cancer Research 2002; 62: 2474-7.
49. Ju YH et al. Dietary genistein negates the inhibitory effect of letrozole on the growth of aromatase-expressing estrogen-dependent human breast cancer cells (MCF-7Ca) in vivo. Carcinogenesis 2008; 29: 2162-8.
50. Wang YU et al. The red clover (Trifolium pratense) isoflavone biochanin A inhibits aromatase activity and expression. Br J Nutr 2008; 99: 303-10.
51. Hirata JD et al. Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial. Fertil Steril 1997; 68: 981-6.
52. Kupfersztain C et al. The immediate effect of natural plant extract, Angelica sinensis and Matricaria chamomilla (Climex) for the treatment of hot flushes during menopause. A preliminary report. Clin Exp Obstet Gynecol 2003; 4: 203-6.
53. Monograph. Angelica sinensis (Dong quai). Altern Med Rev 2004; 9: 429 -33.
54. Chenoy R et al. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ 1994; 308: 501-3.
55. Wiklund IK et al. Effects of a standardized ginseng extract on quality of life and physiological parameters in symptomatic postmenopausal women: a double-blind, placebo-controlled trial. Int J Clin Pharmacol Res 1999; 19: 89-99.
56. Hartley DE et al. Gincosan (a combination of Ginkgo biloba and Panax ginseng): the effects on mood and cognition of 6 and 12 weeks' treatment in postmenopausal women. Nutr Neurosci 2004; 7: 325-33.
57. Komesaroff PA et al. Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women. Climacteric 2001; 4: 144-50.
58. Rotem C, Kaplan B. Phyto-Female Complex for the relief of hot flushes, night sweats and quality of sleep: randomized, controlled, double-blind pilot study. Gynecol Endocrinol 2007; 23: 117-22.
59. Heyerick A et al. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas 2006; 54: 164-75.
60. De Leo V et al. Treatment of menopausal symptoms with non hormonal drug therapy [abstract]. Minerva Ginecol 1998; 50: 207-11.
61. Medicines Control Agency, 2002. MCA investigation of kava kava leads to ban following voluntary withdrawal. Herbal medicine banned following cases of liver toxicity [online]. Available: http://www.mhra.gov.uk/home/groups/es- herbal/documents/websiteresources/con009312.pdf [Accessed 22 December 2008].